Pro Tip: Learn how to use HBI Alerts to follow your favorite topics
Search over 7,000 articles

Search

Search

Search

ADVANCED SEARCH
close
Close

Search   Advanced Search





 
Subscribe
Book a tour

Search

Search

  • Home

  • HBI Headline NewsFree headline news service
  • HBI Deals+Insights
    • HBI News
    • Monthly PDF Library
    • White Papers
  • HBI Intelligence
    • Healthcare Database
    • Market Overviews
    • Special Reports
    • Provider Database
    • Investment Database
    • Market Reports Library
  • HBI Live Events
    • HBI 2027
    • Past Conferences
  • HBI Top Rankings
    • 2026 PE Hot List
    • 2026 Property Investors
    • 2025 Top 250 EMEA
    • 2025 Top 100
    • 2024 Top 100
    • 2023 Top 100
    • 2022 Top 100
    • 2021 Top 100
  • Video Library
  • Login
    • Login
    • Sign me up
  • Memberships
  • News and Data
    Search

    Search
    • Home
    • HBI Headline News
    • HBI Deals+Insights
      • HBI News
      • Monthly PDF Library
      • White Papers
    • HBI Intelligence
      • Healthcare Database
      • Market Overviews
      • Special Reports
      • Provider Database
      • Investment Database
      • Market Reports Library
    • HBI Live Events
      • HBI 2027
      • Past Conferences
    • HBI Top Rankings
      • 2026 PE Hot List
      • 2026 Property Investors
      • 2025 Top 250 EMEA
      • 2025 Top 100
      • 2024 Top 100
      • 2023 Top 100
      • 2022 Top 100
      • 2021 Top 100
    • Video Library
    • Login
      • Login
      • Sign me up
    • Memberships
    Become a Deals+Insights member to read Samsung Biologics pays premium for peptides capacity with €1.6bn PolyPeptide acquisition Find out more
HBI Deals+Insights / M&A/IPOs

Samsung Biologics pays premium for peptides capacity with €1.6bn PolyPeptide acquisition

Martin De Benito Gellner July 23, 2026
Samsung Biologics, a CDMO that is part of the South Korean conglomerate Samsung Group, is spending €1.6 billion buying out PolyPeptide, a listed Swiss CDMO specialising in peptide APIs. This will expand Samsung’s manufacturing capabilities beyond antibodies and antibody-drug conjugates (ADCs), and give it a slice of the critical supply chain infrastructure serving the booming demand for GLP-1s. 
If you are a member please login to continue reading
Login

Get a membership to access premium content

We help businesses in the health care services sector stay ahead of the competition, make the right connections, unlock business growth and make well informed decisions. Here’s how

Exclusive news and strategic insights from across Europe and emerging markets.
The latest M&A stories, interviews with industry leaders and a searchable archive of more than 7,000 news articles.
 
Get in touch to find out which membership is right for you

Or upgrade to include the world's most comprehensive data on European and Emerging Market private operators

Market Reports and data about EMEA health care markets across 23 sub-sectors in more than 100 countries. Operator Database of more than 4,500 health care service companies. Investor Database with details of over 2,000 investments. Plus, everything included in Deals+Insights.
 
Get in touch to find out which membership is right for you

Unsure on which membership is right for you?
Please get in touch with us today.

Call our experts on +00 44 207 183 3779 or email
us at [email protected]

View our privacy policy

Proud to be trusted by 18,727 leading health care businesses, including

Our Services

  • HBI Headline News
  • HBI Deals+Insights
  • HBI Intelligence
  • Conferences
  • HBI Awards

Company

  • About HBI
  • Contact Us

Resources

  • Whitepapers
  • Blog
  • Membership Terms & Conditions
  • Delegate Terms & Conditions
  • Privacy Policy
  • Cookie Policy
Log in
Register
Log in
Register

Our Services

  • HBI Headline News
  • HBI Deals+Insights
  • HBI Intelligence
  • Conferences
  • HBI Awards

Company

  • About HBI
  • Contact Us

Resources

  • Whitepapers
  • Blog
  • Membership Terms & Conditions
  • Delegate Terms & Conditions
  • Privacy Policy
  • Cookie Policy

Find Us

  • LinkedIn
  • Twitter
© Healthcare Europa Limited 2000 - 2026. Trading as Healthcare Business International. Company number 07823199
+44 (0) 207 183 3779 | [email protected] | HBI, Oxford House, 49 Oxford Road, London, N4 3EY
Developed by My Guy Solutions

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

  • check

    All the latest news every week

  • check

    Insights into winning business models

  • check

    Interviews with entrepreneurs

  • check

    Complete M&A coverage

  • check

    ALL private equity investments

  • check

    ALL listed operators

  • check

    Conference reports and presentations

  • check

    Reports on quality, rating sites and more

Know the pulse of the market
from just £1040.

Sign up today
See all our products
Have an account already? Sign in here

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

  • check

    All the latest news every week

  • check

    Insights into winning business models

  • check

    Detailed reports of the sector in China, India, Brazil, UAE and Mexico

  • check

    Interviews with entrepreneurs

  • check

    Complete M&A coverage

  • check

    ALL private equity investments

  • check

    ALL listed operators

  • check

    Conference reports and presentations

Know the pulse of the market
from just £1040.

Sign up today
See all our products
Have an account already? Sign in here

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

  • check

    Identify bid targets

  • check

    Find the top players in 35 countries

  • check

    Research 22 vertical sub-sectors

  • check

    Spot new partners

  • check

    Build new relationships

Instant access plus ongoing updates
from £1,895.

Sign up today
See all our products
Have an account already? Sign in here

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

  • check

    Identify bid targets

  • check

    Find the top players in over 70 countries

  • check

    Research 15 vertical sub-sectors

  • check

    Spot new partners

  • check

    Build new relationships

  • check

    Includes Top 60 in China, Top 70 in India and Top 80 in GCC

Instant access plus ongoing updates
from £1,895.

Sign up today
See all our products
Have an account already? Sign in here
Breaking Barriers 2016
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.